1. Nagao T, Licitra L, Loening T, Vielh P, Williams MD. Salivary duct carcinoma. In: El-Naggar AK, Chan JKC, Rubin Grandis J, Takata T, Slootweg PJ, editors. WHO classification of head and neck tumours. Lyon: International Agency for Research on Cancer; 2017. p. 173–174.
2. Williams MD, Ihrler S, Seethala R. Carcinoma ex pleomorphic adenoma. In: El-Naggar AK, Chan JKC, Rubin Grandis J, Takata T, Slootweg PJ, editors. WHO classification of head and neck tumours. Lyon: International Agency for Research on Cancer; 2017. p. 176–177.
3. Shin S, Desmedt C, Kristiansen G, Reis-Fiho J, Sasano H. Invasive lobular carcinoma. In: Lokuhetty D, White V, Watanabe R, Cree I, editors. WHO classification of tumours breast tumours. Lyon: International Agency for Research on Cancer; 2019. p. 114–118.
4. Al-Baimani K, Bazzarelli A, Clemons M, Robertson SJ, Addison C, Arnaout A. Invasive pleomorphic lobular carcinoma of the breast: pathologic, clinical, and therapeutic considerations. Clin Breast Cancer. 2015;15(6):421–5. https://doi.org/10.1016/j.clbc.2015.06.010.
5. Chen YY, Hwang ES, Roy R, DeVries S, Anderson J, Wa C, et al. Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast. Am J Surg Pathol. 2009;33(11):1683–94. https://doi.org/10.1097/PAS.0b013e3181b18a89.